Starling Oncology STLN
$3.62 −$3.08 (-45.97%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $3.63 +0.28%
Open$6.06
Prev close$6.70
Day range$3.35 – $6.43
Volume23.92M
Market cap$369.21M
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts2
Average target$10.00+176.2% vs. price
- Buy 100%
Low $9.00Now $3.62Avg $10.00High $11.00
Recent rating changes
The last 7 actions on file set price targets from $7.00 to $11.00, averaging $8.71.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 14 Oct 2026 | Needham | BUY | $9.00 |
| 7 Aug 2026 | Needham | BUY | $7.00 |
| 7 Aug 2026 | B. Riley Securities | BUY | $11.00 |
| 3 Aug 2026 | Needham | BUY | $7.00 |
| 15 Jul 2026 | BTIG | BUY | $9.00 |
| 6 Jul 2026 | Lake Street | BUY | $10.00 |
| 8 May 2026 | Noble Financial | BUY | $8.00 |
No comments yet — be the first to weigh in on STLN.
Sign in to join the discussion.